Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Zoom
ZM
|
+$806M |
| 2 |
AbbVie
ABBV
|
+$481M |
| 3 |
T-Mobile US
TMUS
|
+$464M |
| 4 |
Kroger
KR
|
+$430M |
| 5 |
Baidu
BIDU
|
+$423M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$1.35B |
| 2 |
AGN
Allergan plc
AGN
|
+$1.26B |
| 3 |
S
Sprint Corporation
S
|
+$675M |
| 4 |
Amgen
AMGN
|
+$488M |
| 5 |
Humana
HUM
|
+$450M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 23.76% |
| 2 | Technology | 16.41% |
| 3 | Consumer Staples | 10.58% |
| 4 | Consumer Discretionary | 10.13% |
| 5 | Communication Services | 9.97% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1626
Hancock Whitney
HWC
$6.4B
| $5.21M | ﹤0.01% |
245,673
+150,800
| +159% | +$3.11M |
|
|
HTBK
1627
DELISTED
Heritage Commerce
HTBK
| $5.21M | ﹤0.01% |
693,762
+12,500
| +2% | +$98K |
|
1628
Natural Health Trends
NHTC
$15.5M
| $5.19M | ﹤0.01% |
903,976
+20,520
| +2% | +$106K |
|
|
PBIP
1629
DELISTED
Prudential Bancorp, Inc.
PBIP
| $5.17M | ﹤0.01% |
429,002
-9,700
| -2% | -$115K |
|
|
HLG
1630
DELISTED
Hailiang Education Group Inc. American Depositary Shares
HLG
| $5.16M | ﹤0.01% |
125,922
-2,100
| -2% | -$95.5K |
|
1631
Novanta
NOVT
$6.3B
| $5.16M | ﹤0.01% |
48,300
-24,900
| -34% | -$2.31M |
|
1632
Cenovus Energy
CVE
$57.2B
| $5.14M | ﹤0.01% |
1,100,200
-8,138,456
| -88% | -$31.3M |
|
1633
Aaon
AAON
$7.24B
| $5.13M | ﹤0.01% |
+141,681
| New | +$4.76M |
|
1634
Spyre Therapeutics
SYRE
$9.14B
| $5.13M | ﹤0.01% |
22,162
-1,824
| -8% | -$347K |
|
1635
Cousins Properties
CUZ
$4.89B
| $5.12M | ﹤0.01% |
+171,731
| New | +$5.16M |
|
|
MTLS
1636
Materialise
MTLS
$400M
| $5.12M | ﹤0.01% |
227,028
+42,728
| +23% | +$937K |
|
|
PR
1637
Permian Resources
PR
$18B
| $5.12M | ﹤0.01% |
5,751,598
+971,339
| +20% | +$854K |
|
1638
Vanguard Intermediate-Term Corporate Bond ETF
VCIT
$67.6B
| $5.12M | ﹤0.01% |
+53,800
| New | +$4.95M |
|
|
BFX
1639
DELISTED
BowFlex Inc.
BFX
| $5.12M | ﹤0.01% |
+552,089
| New | +$3.35M |
|
|
FOE
1640
DELISTED
Ferro Corporation
FOE
| $5.12M | ﹤0.01% |
428,500
+386,000
| +908% | +$4.15M |
|
1641
Children's Place
PLCE
$54.3M
| $5.11M | ﹤0.01% |
136,660
-546,000
| -80% | -$18.6M |
|
1642
Webster Financial
WBS
$12.8B
| $5.11M | ﹤0.01% |
178,731
+144,500
| +422% | +$3.83M |
|
1643
Gildan
GIL
$10.5B
| $5.11M | ﹤0.01% |
330,000
-1,602,200
| -83% | -$23.7M |
|
|
SCTL
1644
DELISTED
Societal CDMO, Inc. Common Stock
SCTL
| $5.1M | ﹤0.01% |
1,121,100
-110,300
| -9% | -$683K |
|
|
LUMO
1645
DELISTED
Lumos Pharma, Inc. Common Stock
LUMO
| $5.1M | ﹤0.01% |
309,191
-3,900
| -1% | -$46.4K |
|
1646
The Bancorp
TBBK
$2.84B
| $5.08M | ﹤0.01% |
518,000
-322,200
| -38% | -$2.43M |
|
1647
Elbit Systems
ESLT
$36.7B
| $5.03M | ﹤0.01% |
36,700
-5,700
| -13% | -$770K |
|
1648
California Water Service
CWT
$3.12B
| $5.03M | ﹤0.01% |
105,400
-54,252
| -34% | -$2.56M |
|
1649
Lennar Class B
LEN.B
$20.6B
| $5.01M | ﹤0.01% |
114,475
-54,178
| -32% | -$2.05M |
|
1650
Acme United Corp
ACU
$232M
| $5.01M | ﹤0.01% |
217,973
+35,134
| +19% | +$753K |
|
Similar funds
Jim Simons's Q2 2020 Portfolio in Review
As of Q2 2020, Jim Simons held 3,987 positions worth $116B, up 13% from $103B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Jim Simons withdrew a net $8.24B in Q2 2020, closing 596 positions and reducing 1,366 holdings. Its most notable exit was Allergan plc, an estimated $1.26B position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 24% of assets, down from 26% a quarter earlier, followed by Technology and Consumer Staples.
Against the trend, Jim Simons opened a new position in Uber worth $187M.
- Jim Simons's largest Q2 2020 buy was Uber: 6,030,316 shares worth $187M.
- Jim Simons added most to Zoom in Q2 2020, an estimated $806M increase.
- Jim Simons's biggest Q2 2020 reduction was Bristol-Myers Squibb, cutting an estimated $1.35B.
- Jim Simons fully exited Allergan plc in Q2 2020, selling an estimated $1.26B.
- Jim Simons's ten largest holdings make up 14% of its $116B portfolio in Q2 2020.
- Jim Simons opened 584 new positions and closed 596 in Q2 2020.
- Jim Simons's portfolio value rose 13% quarter-over-quarter to $116B.
Based on Renaissance Technologies's 13F filing for Q2 2020, filed 13 Aug 2020.